Alberti KG, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

Article  CAS  PubMed  Google Scholar 

Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12.

Article  PubMed  PubMed Central  Google Scholar 

DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–94.

Article  CAS  PubMed  Google Scholar 

Wu SH, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol. 2010;25(6):375–84.

Article  PubMed  Google Scholar 

Mottillo S, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

Article  PubMed  Google Scholar 

Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–78.

Article  PubMed  Google Scholar 

Sin S et al. Metabolic syndrome and risk of Lung Cancer: an Analysis of Korean National Health Insurance Corporation Database. J Clin Endocrinol Metab, 2020;105(11).

Lee MK, et al. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep. 2020;10(1):2313.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fahed G et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci, 2022;23(2).

Xue Q, et al. Association between baseline and changes in high-sensitive C-reactive protein and metabolic syndrome: a nationwide cohort study and meta-analysis. Nutr Metab (Lond). 2022;19(1):2.

Article  CAS  PubMed  Google Scholar 

Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14(3–4):222–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hotamisligil GS. Foundations of Immunometabolism and Implications for Metabolic Health and Disease. Immunity. 2017;47(3):406–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berbudi A, et al. Type 2 diabetes and its impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442–9.

PubMed  PubMed Central  Google Scholar 

Nishimura S, et al. CD8 + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914–20.

Article  CAS  PubMed  Google Scholar 

Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 2011;11(11):738–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin CA, et al. Systematic review of the Effect of Lifestyle interventions on the components of the metabolic syndrome in south Asian migrants. J Immigr Minor Health. 2018;20(1):231–44.

Article  PubMed  Google Scholar 

Karakayali M, et al. The relationship between the systemic Immune-inflammation index and ischemia with non-obstructive coronary arteries in patients undergoing coronary angiography. Arq Bras Cardiol. 2024;121(2):e20230540.

Article  PubMed  Google Scholar 

Karakayali M, et al. The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis. 2023;34(7):483–8.

Article  PubMed  Google Scholar 

Iida H, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2022;24(1):101–15.

Article  PubMed  Google Scholar 

Tsunematsu M, et al. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy. Ann Gastroenterol Surg. 2023;7(3):503–11.

Article  PubMed  Google Scholar 

Furukawa K, et al. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis. Surg Oncol. 2023;47:101911.

Article  PubMed  Google Scholar 

Takeda Y et al. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery. Asian J Surg. 2024;47(8):3492–8.

Ma R, et al. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer. Surg Oncol. 2024;53:102044.

Article  PubMed  Google Scholar 

Hashimoto I, et al. Clinical impact of the C-reactive protein-albumin-lymphocyte index in post-gastrectomy patients with gastric Cancer. Vivo. 2024;38(2):911–6.

Article  CAS  Google Scholar 

Fukushima N et al. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer. Surg Today. 2024;54(8):943–52.

Liu XY, et al. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. Support Care Cancer. 2023;31(9):533.

Article  PubMed  Google Scholar 

Feng J, et al. Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery. Sci Rep. 2024;14(1):713.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: from the investigation on nutrition status and clinical outcome of common cancers study. Front Immunol. 2023;14:1131496.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, et al. Pre-treatment CRP-Albumin-lymphocyte index (CALLY Index) as a Prognostic Biomarker of Survival in patients with epithelial ovarian Cancer. Cancer Manag Res. 2022;14:2803–12.

Article  PubMed  PubMed Central  Google Scholar 

McQuillan GM, et al. National Health and Nutrition Examination Survey Biospecimen Program: NHANES III (1988–1994) and NHANES 1999–2014. Vital Health Stat. 2015;2(170):1–14.

Google Scholar 

Esser N, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–50.

Article  CAS  PubMed  Google Scholar 

Zhao Y, et al. Association between systemic immune-inflammation index and metabolic syndrome and its components: results from the National Health and Nutrition Examination Survey 2011–2016. J Transl Med. 2023;21(1):691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russo S, et al. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021;12:746151.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin HS et al. Association between Use of Nutritional labeling and the metabolic syndrome and its components. Int J Environ Res Public Health, 2019;16(22).

Zujko ME, Rożniata M, Zujko K. Individual Diet modification reduces the metabolic syndrome in patients before pharmacological treatment. Nutrients, 2021;13(6).

Xu X, et al. Increase in the prevalence of arthritis in adulthood among adults exposed to Chinese famine of 1959 to 1961 during childhood: a cross-sectional survey. Med (Baltim). 2017;96(13):e6496.

Article  Google Scholar 

Guldiken S, et al. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res. 2007;119(1):79–84.

Article  CAS  PubMed  Google Scholar 

Cesari M, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108(19):2317–22.

Article